BridgeMD
New treatment option for Hypertension in Pregnancy
Official title Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
ClinicalTrials.gov ID: NCT06842875
What this study is testing
- What it's testing
- This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60, women only
You may be able to join if
- Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island
- Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant
- English-, Spanish-, Portuguese-, or Haitian-Creole-speaking
- Smartphone ownership
You likely can't join if
- Prior enrollment in this trial
- Prisoners or incarcerated people
- Inability or unwillingness to provide informed consent
- Inability to communicate with study team, despite an interpreter
The study team makes the final eligibility decision.
Where it's taking place
- Newport, Rhode Island, United States
- Providence, Rhode Island, United States
- Wakefield, Rhode Island, United States
- Warwick, Rhode Island, United States
- Woonsocket, Rhode Island, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Newport, Rhode Island, United States; Providence, Rhode Island, United States; Wakefield, Rhode Island, United States; Warwick, Rhode Island, United States; Woonsocket, Rhode Island, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.